Azilect
Rasagiline Rasagiline is a propargylamine-based medication indicated to treat Parkinson’s Disease. Status: Completed FDA Approved
-
-
Vimpat
Lacosamide Lacosamide (Vimpat) is an oral medication indicated for the treatment of partial-onset seizures. Status: Completed FDA Approved
-
Allergan
UbreIvy UbreIvy is an oral medication made for immediate treatment of migraines. Status: Completed FDA Approved
-
CASSAVA
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Morbi sagittis bibendum turpis, convallis faucibus purus sollicitudin at. Etiam ornare cursus turpis, eget finibus erat imperdiet quis. Etiam rutrum facilisis purus id porta. Praesent nibh nisl, elementum ac nibh non, ultrices blandit lectus. Nulla vitae tellus nec urna rhoncus iaculis blandit posuere dui. Suspendisse mattis, lectus…
-
ACADIA
Pimavanserin Pimavanserin is indicated to treat psychosis in patients with Parkinson’s Disease. Status: Completed FDA Approved
-
UCB
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Morbi sagittis bibendum turpis, convallis faucibus purus sollicitudin at. Etiam ornare cursus turpis, eget finibus erat imperdiet quis. Etiam rutrum facilisis purus id porta. Praesent nibh nisl, elementum ac nibh non, ultrices blandit lectus. Nulla vitae tellus nec urna rhoncus iaculis blandit posuere dui. Suspendisse mattis, lectus…
-
ELI LILY
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Morbi sagittis bibendum turpis, convallis faucibus purus sollicitudin at. Etiam ornare cursus turpis, eget finibus erat imperdiet quis. Etiam rutrum facilisis purus id porta. Praesent nibh nisl, elementum ac nibh non, ultrices blandit lectus. Nulla vitae tellus nec urna rhoncus iaculis blandit posuere dui. Suspendisse mattis, lectus…
-
ATHIRA
Fosgonimeton This clinical trial examines the long-term tolerability of Fosgonimeton (ATH-1017) over an additional 4-year period in subjects with mild to moderate Alzheimer’s disease. This trial is an extension of Study ATH-1017-AD-0201 and Study ATH-1017-AD-0202. Status: ACTIVE, NOT RECRUITING
-
Novartis
Exelon Patch The Exelon Patch is indicated for patients with mild to severe Alzheimer’s Disease to improve nerve cells function. Status: Completed FDA Approved
-
PASSAGE
Fingolimod Fingolimod (KESIMPTA) is an oral medication indicated for the treatment of relapsing multiple sclerosis. Status: Completed FDA Approved
